|
LOC728323 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62581059726108E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24555921132696E-12 |
| Normal-vs-Stage2 |
1.40559999994849E-06 |
| Normal-vs-Stage3 |
2.23450036251904E-10 |
| Normal-vs-Stage4 |
4.45710002239252E-09 |
| Stage1-vs-Stage2 |
8.116000E-01 |
| Stage1-vs-Stage3 |
2.713600E-01 |
| Stage1-vs-Stage4 |
4.968400E-01 |
| Stage2-vs-Stage3 |
3.191400E-01 |
| Stage2-vs-Stage4 |
4.637000E-01 |
| Stage3-vs-Stage4 |
8.831200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.38959971202257E-10 |
| Normal-vs-AfricanAmerican |
1.816520E-03 |
| Normal-vs-Asian |
1.95790000001583E-06 |
| Caucasian-vs-AfricanAmerican |
9.643500E-02 |
| Caucasian-vs-Asian |
3.296600E-01 |
| AfricanAmerican-vs-Asian |
4.435800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.77780046029375E-11 |
| Normal-vs-Female |
1.98996374933813E-12 |
| Male-vs-Female |
5.928400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.81720235817806E-11 |
| Normal-vs-Age(41-60Yrs) |
9.77329328577525E-12 |
| Normal-vs-Age(61-80Yrs) |
2.26910046308149E-10 |
| Normal-vs-Age(81-100Yrs) |
1.228580E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.915000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.567400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.596780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.962800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.659980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.126600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.822200E-02 |
| Classical-VS-Follicular |
8.506600E-01 |
| Classical-VS-Other |
7.162200E-01 |
| Classical-VS-Normal |
6.50039999605667E-09 |
| Tall-VS-Follicular |
3.295900E-02 |
| Tall-VS-Other |
4.529200E-01 |
| Tall-VS-Normal |
3.09450021163116E-10 |
| Follicular-VS-Other |
7.108600E-01 |
| Follicular-VS-Normal |
4.09599999473542E-08 |
| Other-VS-Normal |
6.481600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.45534711954087E-12 |
| Normal-vs-N1 |
5.32589999879818E-08 |
| N0-vs-N1 |
8.018400E-01 |
|
|
